Henry Schein | HSIC - Cash And Equivalent

Stock Price
76.58
Daily Change
1.32 1.75%
Monthly
-2.51%
Yearly
-4.10%
Q1 Forecast
73.16

Henry Schein reported $136M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Agilent USD 1.79B 254M Sep/2025
Align Technology USD 1B 103.43M Sep/2025
Bruker USD 293.1M 201.1M Sep/2025
Cardinal Health USD 2.78B 1.82B Dec/2025
Charles River Laboratories USD 207.1M 24.27M Sep/2025
Cigna USD 6.02B 1.7B Sep/2025
Cooper Companies USD 124.9M 13.3M Jun/2025
CVS Health USD 9.1B 2.69B Sep/2025
Danaher USD 4.62B 3.09B Dec/2025
Dentsply International USD 363M 4M Sep/2025
Encompass Health USD 48.7M 50.4M Sep/2025
Henry Schein USD 136M 9M Sep/2025
Idexx Laboratories USD 208.17M 43.57M Sep/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
Laboratory Of America USD 598.1M 49.2M Sep/2025
McKesson USD 2.96B 1.05B Dec/2025
Mettler Toledo International USD 69.06M 7.24M Sep/2025
Owens Minor USD 32.84M 5.42M Sep/2025
Quest Diagnostics USD 432M 113M Sep/2025
Revvity USD 931.39M 60.46M Sep/2025
Stryker USD 3.26B 881M Sep/2025
Tenet Healthcare USD 2.98B 350M Sep/2025
Thermo Fisher Scientific USD 9.85B 7.87B Dec/2025
Universal Health Services USD 112.9M 24.7M Sep/2025
Waters USD 459.12M 91.9M Sep/2025
Zimmer Biomet Holdings USD 1.29B 735.8M Sep/2025
Zoetis USD 2.08B 649M Sep/2025